Incretin effect: difference between revisions
Diff·revision 42 → 43·00:31, 30 Apr 2025
Difference between revision 42 and revision 43 of Incretin effect. 3 lines changed; the page grew by 165 bytes.
| Revision 42 — 15:29, 19 Apr 2025 TrialsTabitha (talk) correct percentage: source reports placebo-adjusted 5,768 bytes ±0 | Revision 43 — 00:31, 30 Apr 2025 Peptide_Pete (talk) convert list to prose 5,933 bytes +165 | ||
|---|---|---|---|
| 40 | <ref name="nauck2018">Nauck MA, Meier JJ. "Incretin hormones: their role in health and disease." ''Diabetes, Obesity and Metabolism'' 20(Suppl 1):5–21 (2018). DOI:10.1111/dom.13129. PMID 29364588.</ref> | 40 | <ref name="nauck2018">Nauck MA, Meier JJ. "Incretin hormones: their role in health and disease." ''Diabetes, Obesity and Metabolism'' 20(Suppl 1):5–21 (2018). DOI:10.1111/dom.13129. PMID 29364588.</ref> |
| 41 | 41 | ||
| + | 42 | == Further reading == | |
| + | 43 | * Campbell JE, Drucker DJ. "Pharmacology, physiology, and mechanisms of incretin hormone action." ''Cell Metabolism'' 17(6):819–837 (2013). | |
| + | 44 | ||
| 42 | == See also == | 45 | == See also == |
| 43 | * [[Glucagon-like peptide-1]] | 46 | * [[Glucagon-like peptide-1]] |